Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop

Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring... Special Atricle Perspectives of Novel Imaging Techniques for Staging,  Therapy Response Assessment, and Monitoring of  Surveillance in Lung Cancer Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop Thomas Henzler, MD,* Peter Goldstraw, MD,† Frederik Wenz, MD,‡ Robert Pirker, MD,§ Walter Weder, MD,║ Paul Apfaltrer, MD,* Mathias Meyer, MD,* Karen Buesing, MD,* Lucio Crino, MD,¶ Dean Fennell, MD, PhD,# Christian Fink, MD,** Dominique Grunenwald, MD,†† Christian Manegold, MD,‡‡ Lothar Pilz, MA,§§ Stefan O. Schoenberg, MD,* Senan Suresh, MD,║║ Johan Vansteenkiste, MD, PhD,¶¶ Wieland Voigt, MD,## Björn Wängler, PhD,***and Gerald Schmid-Bindert, MD,‡‡ assessment such as Response Evaluation Criteria in Solid Tumors or Abstract: Modern imaging techniques that can provide functional World Health Organization criteria—that exclusively focus on the information on tumor vascularization, metabolic activity, or cellular- change in tumor size—are of less value for response assessment in ity have seen significant improvements over the past decade. However, modern thoracic oncology. The aim of this article comprises two parts: most of these techniques are currently not broadly utilized neither in a short review of the most promising state-of-the-art imaging tech- clinical trials nor in clinical routine, although there is a large agree- niques that have the potential to play a larger role in thoracic oncol- ment on the fact that conventional approaches for therapy http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Perspectives of Novel Imaging Techniques for Staging, Therapy Response Assessment, and Monitoring of Surveillance in Lung Cancer Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop

Schmid-Bindert, Gerald
Journal of Thoracic Oncology , Volume 10 (2) – Feb 1, 2015
Download PDF
13 pages

Loading next page...
 
/lp/wolters-kluwer-health/perspectives-of-novel-imaging-techniques-for-staging-therapy-response-GKRtwon2NT

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2014 by the International Association for the Study of Lung Cancer
ISSN
1556-0864
DOI
10.1097/JTO.0000000000000412
pmid
25611226
Publisher site
See Article on Publisher Site

Abstract

Special Atricle Perspectives of Novel Imaging Techniques for Staging,  Therapy Response Assessment, and Monitoring of  Surveillance in Lung Cancer Summary of the Dresden 2013 Post WCLC-IASLC State-of-the-Art Imaging Workshop Thomas Henzler, MD,* Peter Goldstraw, MD,† Frederik Wenz, MD,‡ Robert Pirker, MD,§ Walter Weder, MD,║ Paul Apfaltrer, MD,* Mathias Meyer, MD,* Karen Buesing, MD,* Lucio Crino, MD,¶ Dean Fennell, MD, PhD,# Christian Fink, MD,** Dominique Grunenwald, MD,†† Christian Manegold, MD,‡‡ Lothar Pilz, MA,§§ Stefan O. Schoenberg, MD,* Senan Suresh, MD,║║ Johan Vansteenkiste, MD, PhD,¶¶ Wieland Voigt, MD,## Björn Wängler, PhD,***and Gerald Schmid-Bindert, MD,‡‡ assessment such as Response Evaluation Criteria in Solid Tumors or Abstract: Modern imaging techniques that can provide functional World Health Organization criteria—that exclusively focus on the information on tumor vascularization, metabolic activity, or cellular- change in tumor size—are of less value for response assessment in ity have seen significant improvements over the past decade. However, modern thoracic oncology. The aim of this article comprises two parts: most of these techniques are currently not broadly utilized neither in a short review of the most promising state-of-the-art imaging tech- clinical trials nor in clinical routine, although there is a large agree- niques that have the potential to play a larger role in thoracic oncol- ment on the fact that conventional approaches for therapy

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Feb 1, 2015

References

  • The revised TNM staging system for lung cancer
    Rami-Porta
  • New strategies in non-small cell lung cancer: improving outcomes in chemoradiotherapy for locally advanced disease
    Rengan
  • Can imaging help improve the survival of cancer patients?
    Miles
  • Imaging of lung cancer in the era of molecular medicine
    Nishino
  • Revised RECIST guideline version 1.1: What oncologists want to know and what radiologists need to know
    Nishino
  • Personalized tumor response assessment in the era of molecular medicine: Cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST
    Nishino
  • When progressive disease does not mean treatment failure: Reconsidering the criteria for progression
    Oxnard
  • High-grade soft-tissue sarcomas: Tumor response assessment–pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria
    Stacchiotti
  • Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals
    Zhao
  • Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria
    Marten
  • Lung cancer: Computerized quantification of tumor response–initial results
    Zhao
  • Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer
    Zhao
  • Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence
    Mozley
  • Measurement of tumor volumes improves RECIST-based response assessments in advanced lung cancer
    Mozley
  • CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool
    Nishino
  • Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy
    Dehing-Oberije
  • Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapy
    Alexander
  • Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer
    Kozak
  • Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria
    Wolchok
  • Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria
    Choi
  • Prospective assessment of discontinuation and reinitiation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of everolimus
    Riely
  • Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer
    Jackman
  • Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI
    Nishino
  • New CT response criteria in non-small cell lung cancer: Proposal and application in EGFR tyrosine kinase inhibitor therapy
    Lee
  • Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small-cell lung cancers
    Chaft
  • Material differentiation by dual energy CT: Initial experience
    Johnson
  • Dual-energy CT: Radiation dose aspects
    Henzler
  • Clinical utility of dual-energy CT in the evaluation of solitary pulmonary nodules: Initial experience
    Chae
  • Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: Is iodine-related attenuation a potential indicator of tumor response?
    Apfaltrer
  • Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: A systematic review and meta-analysis of clinical trials
    Je
  • Dual-energy-CT of hypervascular liver lesions in patients with HCC: Investigation of image quality and sensitivity
    Altenbernd
  • Single-phase dual-energy CT allows for characterization of renal masses as benign or malignant
    Graser
  • Functional imaging of lung cancer using dual energy CT: How does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?
    Schmid-Bindert
  • Dual-energy CT in patients treated with anti-angiogenic agents for non-small cell lung cancer: New method of monitoring tumor response?
    Kim
  • Dual-energy CT can evaluate both hilar and mediastinal lymph nodes and lesion vascularity with a single scan at 60 seconds after contrast medium injection
    Ogawa
  • Prediction of postoperative pulmonary function: Preliminary comparison of single-breath dual-energy xenon CT with three conventional methods
    Yanagita
  • Whole tumour perfusion of peripheral lung carcinoma: Evaluation with first-pass CT perfusion imaging at 64-detector row CT
    Li
  • Functional CT: Lung nodule evaluation
    Swensen
  • Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material
    Swensen
  • Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material–a preliminary report
    Swensen
  • Lung nodule enhancement at CT: Multicenter study
    Swensen
  • Solitary pulmonary nodule: Preliminary study of evaluation with incremental dynamic CT
    Yamashita
  • Solitary pulmonary nodules: Evaluation of blood flow patterns with dynamic CT
    Zhang
  • Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma
    Tateishi
  • Tumor response to radiotherapy regulated by endothelial cell apoptosis
    Garcia-Barros
  • Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography
    Ng
  • Tumor response in patients with advanced non-small cell lung cancer: Perfusion CT evaluation of chemotherapy and radiation therapy
    Wang
  • Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: A new method of monitoring treatment?
    Lind
  • Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy: Initial experience
    Fraioli
  • Intraobserver and interobserver agreement of volume perfusion CT (VPCT) measurements in patients with lung lesions
    Sauter
  • Dynamic volume perfusion CT in patients with lung cancer: Baseline perfusion characteristics of different histological subtypes
    Shi
  • Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Peters
  • Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer
    De Leyn
  • Guidelines Working Group. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Crinò
  • 18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients
    Toba
  • Integrated FDG-PET/CT vs. standard radiological examinations: Comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients
    Takenaka
  • American College of Chest Physicians. Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition)
    Rubins
  • PET/CT using 18F-FDG in suspected lung cancer recurrence: Diagnostic value and impact on patient management
    Keidar
  • Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: Experience with 241 patients
    Kanzaki
  • Diagnosis of recurrence and assessment of post-recurrence survival in patients with extracranial non-small cell lung cancer evaluated by 18F-FDG PET/CT
    Jiménez-Bonilla
  • Detecting recurrent or residual lung cancer with FDG-PET
    Inoue
  • Role of FDG-PET scans in staging, response assessment, and follow-up care for non-small cell lung cancer
    Cuaron
  • Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer
    Choi
  • Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria
    Caulo
  • From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
    Wahl
  • Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for non-small cell lung cancer (NSCLC): The technical basis, ICRU-target volumes, problems, perspectives
    Nestle
  • Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer
    Grills
  • Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer
    Deniaud-Alexandre
  • New strategy for monitoring targeted therapy: Molecular imaging
    Teng
  • Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography
    Zander
  • Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3′-deoxy-3′-18F-fluorothymidine PET
    Kahraman
  • Early detection of erlotinib treatment response in NSCLC by 3′-deoxy-3′o-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET)
    Ullrich
  • A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors
    Kayani
  • Guidelines Working Group. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    D'Addario
  • Detection of bone metastases in non-small cell lung cancer patients: Comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDG-PET/CT, and bone scintigraphy
    Takenaka
  • A meta-analysis of (1)(8)FDG-PET-CT, (1)(8)FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer
    Qu
  • Meta-analysis: Comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer
    Chang
  • Mediastinal lymph nodes: Assessment with diffusion-weighted MR imaging
    Koşucu
  • Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: Which is better?
    Wu
  • Mediastinal nodes in patients with non-small cell lung cancer: MRI findings with PET/CT and pathologic correlation
    Yeh
  • Preoperative staging of non-small-cell lung cancer: Comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
    Sommer
  • N stage disease in patients with non-small cell lung cancer: Efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT
    Ohno
  • Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: Quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient
    Nakayama
  • Mediastinal lymph nodes in patients with non-small cell lung cancer: Preliminary experience with diffusion-weighted MR imaging
    Hasegawa
  • Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results
    Nomori
  • Diffusion-weighted MRI versus 18F-FDG PET/CT: Performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy
    Ohno
  • Na+/H+ exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes
    Reshkin
  • In vivo NMR imaging of sodium-23 in the human head
    Hilal
  • Two-dimensional radial acquisition technique with density adaption in sodium MRI
    Konstandin
  • Quantitative and qualitative (23)Na MR imaging of the human kidneys at 3 T: Before and after a water load
    Haneder
  • Spectrally weighted twisted projection imaging: Reducing T2 signal attenuation effects in fast three-dimensional sodium imaging
    Boada
  • Quantification and imaging of myocardial sodium and creatine kinase metabolites
    Bottomley
  • Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging
    Ouwerkerk
  • Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI
    Ouwerkerk
  • Imaging of tumor viability in lung cancer: Initial results using 23Na-MRI
    Henzler
  • Thoracic staging in lung cancer: Prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CT
    Heusch
  • Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice
    Al-Nabhani
  • A proposal for combined MRI and PET/CT interpretation criteria for preoperative nodal staging in non-small-cell lung cancer
    Kim
  • Multiplanar display of spiral CT data of the pulmonary hila in patients with lung cancer. Preliminary observations
    Padhani
  • CT angiography of the pulmonary artery in patients with bronchial carcinoma
    Stöblen
  • Application of spiral CT and post-image processing technique in the staging of central lung cancer
    Wang
  • Members of IASLC Staging Committee. The IASLC lung cancer staging project: A proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer
    Rusch